Founded in Shoreditch in 2011, Grind has spread across London and evolved into an award-winning group of nine café-bars and restaurants serving coffee, food and cocktails to a killer soundtrack. Grind plans to open 10 new restaurants & has signed an agreement to open in airports and train stations.
days to go:
Expired
investment:
£1,914,940
Hybrid Air Vehicles (HAV) is a company that is aiming to make air travel sustainable and carbon-free. It's product, Airlander, is the world’s first full-scale hybrid aircraft. By 2025, the company estimates that Airlander will fly with up to 90% fewer emissions than other aircraft. The market for Airlander technology is estimated at over US$ 50 billion over the next 20 years. HAV is focusing on securing launch orders for the production of Airlander 10, it's all-electric aircraft, from commercial and defence contractors. The company has featured in publications such as The Telegraph, Financial Times, BBC, GQ and Robb Report. HAV will use the investment to underpin its operations and contract discussions during Covid-19 recovery.
days to go:
Expired
investment:
£1,900,490
Sugru is a mouldable glue designed for fixing and making things. The adhesive fixes to almost any surface and overnight turns into a strong durable rubber which is cold and heat resistant, waterproof, U.V proof and still flexible and removable. The product is currently available in over 5000 stores and has plans to launch a new Sugru Formula in 2017 which is suitable for all the family, including children from 8 years old.
days to go:
Expired
investment:
£1,896,080
Emortal is on a mission to enable families to protect, preserve and pass on their legacies digitally. The company converts a family's digital content into the latest file formats, stores it in a digital vault, and futureproofs it via Google's proprietary technology to provide access anytime, anywhere, and across any device when requested by family members. Emortal assesses that its portal has been designed to integrate its preservation technology with a future proof legacy fund to pay for the continuous updates needed to ensure that the digital family heritage lasts for generations to come. Emortal was subject to an acquisition offer of USD 12.1 million by Microsoft in 2010. The company aims to launch in Q3 2021 to capture the interest of other big technology companies to invest in its business model.
days to go:
Expired
investment:
£1,886,340
ENSO is developing a new generation of cleaner, sustainable tyres and plans to disrupt the £200 billion global tyre market. It argues that conventional tyres are largely made of fossil fuels and contribute up to 28%+ of all primary ocean microplastics upon wearing down. It further points out that the increased weight and torque of electric vehicles wears tyres even faster, emitting more pollution. ENSO is addressing this crisis by developing sustainable tyres for EVs, to help reduce carbon emissions in line with the UK Government’s 'Net-Zero Strategy'. Its business is built on a direct-to-customer ‘Pay-per-Mile’ model serving EV-carmakers, fleets and private individuals directly. It claims that its latest energy-efficient tyres have achieved ‘A’ energy efficiency ratings by TÜV SÜD in Germany. The company will use the investment to deliver its first commercial tyres to EV-carmakers in 2021, and launch trials via London FreightLab, with Transport for London and DPD, with plans to expand to California by 2022.
days to go:
Expired
investment:
£1,873,760
Pavegen is at the forefront of transforming cities through groundbreaking kinetic technology that converts foot traffic into renewable energy and valuable data. Their impressive 100% revenue growth in 2022, reaching £2 million with an EBITDA of -£627,000, has spurred them to seek funding to capitalize on the rapidly expanding ESG market, anticipated to be worth $50 trillion by 2025. With the pressing need for climate action, Pavegen's solution revolves around generating off-grid energy and data from urban foot traffic, fundamentally reshaping how cities and institutions interact with renewable energy sources and engage with their communities, contributing to a more sustainable planet. Their business model includes large-scale installations, revenue generated from their data platform and analytics, and multiple income streams. In a competitive landscape, Pavegen is a pioneering market leader, offering an efficient means of harnessing energy from motion through their core IP electromagnetic technology.
The raised funds will support the expansion of sales and marketing efforts, technology scaling, and innovation, including the development of new products such as kinetic roads. Pavegen has gained the support of institutional investors like the Hinduja Group and Tamar Capital, propelling urban transformation. They serve a diverse customer base globally, including blue-chip companies, governmental bodies, and various entities in 37 countries. Pavegen holds three international patents, positioning them as a trailblazer in kinetic energy technology with applications in various fields.
days to go:
Expired
investment:
£1,860,345
A current account for small business owners and the self-employed that automates their accounting and taxes. Coconut informs customers about transactions on their account that that are eligible for a tax deduction and automatically completes a tax return. It also provides a tax bill forecast and shows guidance on tax rules and regulations. Coconut currently looks after 3,000 accounts and has pre-registered 5,000 limited companies with total transactions processed exceeding £12m.
days to go:
Expired
investment:
£1,857,450
The Wild Beer Co have created a Wildly Different beer by using wild fermentation and barrel aging. They have fused beer with different tastes such as fruit flavours, sours, herbal, spicy and even using smoke techniques to flavour the beer.
days to go:
Expired
investment:
£1,760,340
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.
days to go:
Expired
investment:
£1,753,067
Tribe are a modern, natural nutrition brand, based online and tailored to the customer. The UK sport nutrition market is growing at 23% a year and Tribe have already gained 25,000 members purchasing products from them. All products are formulated for performance and made from the highest natural ingredients.
days to go:
Expired
investment:
£1,747,470
